NCT03388151

Propofol Versus Midazolam for Lower Gastrointestinal Endoscopy

Effect of Use of Propofol Versus Use of Midazolam as Sedative Agent in Patients With Liver Cirrhosis Presented for Lower Gastrointestinal Endoscopy, Randomised Controlled Trial

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Sherief Abd-Elsalam · Academic / Other
• Sex: All
• Age: 45 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy

Detailed description

Effect of use of propofol versus use of midazolam as sedative agent in patients with liver cirrhosis presented for lower gastrointestinal endoscopy, Randomised controlled trial.

Conditions

• Cirrhosis, Liver

Interventions

Type	Name	Description
DRUG	Midazolam	Midazolam 3 mg i.v added to fentanyl 0.5 ug/kg till reaching satisfactory level of sedation
DRUG	Propofol	Propofol 1 mg/kg i.v added to fentanyl 0.5 ug/kg i.v till reaching satisfactory level of sedation

Timeline

• Start date: 2016-04-01
• Primary completion: 2022-11-11
• Completion: 2022-12-11
• First posted: 2018-01-02
• Last updated: 2018-08-27

Locations

1 site across 1 country: Egypt